Should fludrocortisone be stopped when checking cortisol levels for adrenal insufficiency?

No, fludrocortisone does NOT need to be stopped when checking cortisol levels for adrenal insufficiency.

Fludrocortisone is a mineralocorticoid replacement medication that does not interfere with cortisol measurement or interpretation when evaluating for adrenal insufficiency. The key distinction is that fludrocortisone acts primarily on mineralocorticoid receptors to maintain electrolyte balance and blood pressure, while cortisol testing evaluates glucocorticoid axis function.

Key Reasoning

Why Fludrocortisone Doesn't Interfere

• Fludrocortisone has minimal glucocorticoid activity at replacement doses (0.05-0.2 mg daily) 1
• Morning cortisol testing evaluates the hypothalamic-pituitary-adrenal (HPA) axis recovery, which is independent of mineralocorticoid replacement
• The 2024 European Society of Endocrinology/Endocrine Society guidelines recommend morning serum cortisol as the first test for confirming HPA axis recovery, with no mention of stopping fludrocortisone 2

What Actually Needs to Be Stopped

Glucocorticoids are what must be tapered or held when testing for adrenal insufficiency recovery:

• Testing should only occur when patients are on physiologic daily dose equivalents (e.g., 4-6 mg prednisone or 15-25 mg hydrocortisone) 2
• Testing is not recommended while patients remain on supraphysiologic glucocorticoid doses 2
• Long-acting glucocorticoids (dexamethasone, betamethasone) should be switched to shorter-acting agents (hydrocortisone, prednisone) before testing 2

Diagnostic Approach

Morning Cortisol Interpretation (while on physiologic glucocorticoid doses):

1. >300 nmol/L (10 μg/dL): HPA axis recovered, glucocorticoids can be safely stopped 2
2. 150-300 nmol/L (5-10 μg/dL): Continue physiologic glucocorticoid dose, repeat testing in weeks to months 2
3. <150 nmol/L (5 μg/dL): Continue physiologic glucocorticoid dose, repeat testing after several months 2

Important Caveats

Fludrocortisone is specifically NOT recommended for glucocorticoid-induced adrenal insufficiency 2. This guideline applies to patients whose adrenal suppression results from exogenous glucocorticoid therapy. However, for primary adrenal insufficiency (Addison's disease), fludrocortisone remains essential replacement therapy 3, 4, 1.

Clinical Pitfall to Avoid

The common error is confusing mineralocorticoid replacement (fludrocortisone) with glucocorticoid replacement when evaluating HPA axis recovery. While research shows fludrocortisone can inhibit ACTH response to CRH stimulation at doses ≥0.075 mg 5, this does not affect the clinical utility of morning cortisol testing for assessing endogenous cortisol production capacity. The morning cortisol reflects the patient's ability to produce cortisol from their own adrenal glands, which is the relevant clinical question.

Bottom line: Continue fludrocortisone during cortisol testing for adrenal insufficiency evaluation. Only glucocorticoid therapy needs to be at physiologic replacement doses or tapered appropriately before testing.